☆ 4.7 Article

Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment

SCIENTIFIC REPORTS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond

Alessandro Rizzo et al.

Summary: This article discusses potential predictors of response to ICIs in breast cancer, including PD-L1 expression, TILs, TMB, and other biomarkers. Valuable data on predictive biomarkers have emerged, supporting the use of immunotherapy in metastatic triple-negative breast cancer, although further investigations are needed.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer

Elisa Agostinetto et al.

Summary: This review focuses on the use of immunotherapeutic strategies in triple negative breast cancer (TNBC), discussing evidence from early and advanced TNBC and novel immunomodulatory approaches. PD-1 blockade has been approved for TNBC treatment, but challenges include predictive biomarker identification and balancing efficacy with toxicity. Evaluation of treatment combinations and new immunotherapeutic strategies beyond PD-1 blockade is ongoing.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Review Oncology

Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice

Francesca Carlino et al.

Summary: Triple-negative breast cancer has historically been considered difficult to treat, with chemotherapy as the main treatment option. However, recent advances in genomics and immunology have led to the development of novel therapeutic strategies, such as immunotherapy, to enhance immune response and overcome drug resistance in TNBC. It is crucial to identify more sensitive biomarkers in the field of breast cancer immune oncology to improve patient outcomes.

CANCERS (2022)

添加到收藏夹

Article Immunology

Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model

Vahid Khaki Bakhtiarvand et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

添加到收藏夹

Review Oncology

Immunotherapy in triple-negative breast cancer: A literature review and new advances

Guillermo Arturo Valencia et al.

Summary: Triple-negative breast cancer is a complex and heterogeneous disease with historically limited treatment options. Immunotherapy has emerged as an important alternative treatment, showing impact on progression-free survival and overall survival in selected populations. Further research is needed to explore potential predictive biomarkers of response to treatment in this subtype of breast cancer.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Clinical trials of immunotherapy in triple-negative breast cancer

Frederick M. Howard et al.

Summary: Immunotherapy has shown promise in the treatment of TNBC, but responses are limited to a subset of patients. Combination chemoimmunotherapy approaches have been more successful, and pembrolizumab is approved for advanced TNBC in combination with chemotherapy.

BREAST CANCER RESEARCH AND TREATMENT (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion

Qiqun Zeng et al.

SCIENCE (2022)

添加到收藏夹

Article Oncology

Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice

James D. Barnett et al.

Summary: This study confirmed the ability of near-infrared photoimmunotherapy to eliminate myeloid-derived suppressor cells in tumor-bearing mice, reducing immune suppression. The observed metabolic changes may provide potential biomarkers and metabolic targets for MDSC depletion.

CANCERS (2022)

添加到收藏夹

Review Oncology

Immunology and immunotherapy in breast cancer

Vladimir Semiglazov et al.

Summary: This review provides clinical evidence of immune checkpoint inhibition in the curative treatment of various breast cancer subtypes, as well as the correlation between levels of tumor infiltrating lymphocytes and regulatory genes.

CANCER BIOLOGY & MEDICINE (2022)

添加到收藏夹

Review Oncology

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer

Chenyi Luo et al.

Summary: Breast cancer is the most common cancer in women worldwide, with triple-negative breast cancer being a subtype that lacks effective targeted treatments. Immunotherapy, particularly immune checkpoint inhibitors, has shown promising results in treating triple-negative breast cancer. The recent approval of atezolizumab in combination with nab-paclitaxel for PD-L1-positive advanced or metastatic triple-negative breast cancer has opened up new possibilities in immunotherapy for this aggressive disease.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer

Reza Mehdizadeh et al.

Summary: Triple-negative breast cancer is an aggressive subtype affecting young women, with chemotherapy as the main treatment choice. Some chemotherapies have been shown to induce immunogenic cell death and elicit an adaptive immune response. Mathematical modeling predicts a prophylactic and therapeutic vaccination effect by injecting dormant cells with active interferon signaling. This approach shows potential in suppressing tumor growth through an adaptive immune response.

CANCERS (2021)

添加到收藏夹

Article Oncology

Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model

Sadiya Parveen et al.

Summary: Selective depletion of IL-4R-bearing cells in TNBC using DABIL-4 led to direct killing of tumor cells and depletion of immunosuppressive cells, resulting in an enhanced antitumor response. The immunotherapeutic function of DABIL-4 is likely mediated through the depletion of MDSCs, TAMs, and regulatory T cells in the tumor microenvironment.

MOLECULAR ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer

James Isaacs et al.

Summary: Immune checkpoint blockade has shown clinical benefit in triple-negative breast cancer, but only a minority of patients truly benefit from it with potential additional toxicities. ICB-based regimens are now standard-of-care in certain TNBC subpopulations, and research into novel biomarkers may improve patient selection for personalized ICB therapies.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment

Xiaowei Wang et al.

Summary: Triple-negative breast cancer (TNBC) is a difficult-to-treat subtype of breast cancer, and the immune-related gene prognostic index (IRGPI) is significantly associated with immune cell compositions, tumor-infiltrating lymphocyte status, and PD-1/PD-L1 expression in the tumor-immune microenvironment. IRGPI shows promise as a biomarker for predicting patient survival and immune characteristics in TNBC.

CANCERS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway

Kevin Alicea-Torres et al.

Summary: Type I interferon receptor signaling serves as a universal mechanism restricting MDSC suppressive activity, with downregulation of IFNAR1 required for activation of immune suppressive properties in MDSC. Modulating IFNAR1 undermines MDSC suppressive activity and has potent anti-tumor effects.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Oncology

Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling

Jiale An et al.

Summary: Chronic stress may accumulate MDSCs via activation of beta-adrenergic signaling and IL-6/STAT3 pathway, thereby promoting breast carcinoma metastasis.

ONCOIMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach

Yacine Bareche et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

添加到收藏夹

Article Oncology

TNFR2+TILs are significantly associated with improved survival in triple-negative breast cancer patients

Maya Dadiani et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

添加到收藏夹

Review Oncology

The Landscape of Targeted Therapies in TNBC

Elena Vagia et al.

CANCERS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The premise of personalized immunotherapy for cancer dormancy

Masoud H. Manjili

ONCOGENE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A QSP model of prostate cancer immunotherapy to identify effective combination therapies

Roberta Coletti et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Review Oncology

Triple-negative breast cancer therapy: Current and future perspectives (Review)

Kwang-Ai Won et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2020)

添加到收藏夹

Review Oncology

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy

Yufei Wang et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis

Zhao-hua Gao et al.

BMC CANCER (2020)

添加到收藏夹

Review Oncology

A review of cancer immunotherapy: from the past, to the present, to the future

K. Esfahani et al.

CURRENT ONCOLOGY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Advances in Targeted Therapies for Triple-Negative Breast Cancer

Kelly E. McCann et al.

DRUGS (2019)

添加到收藏夹

Article Medicine, General & Internal

MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers

Livingstone Fultang et al.

EBIOMEDICINE (2019)

添加到收藏夹

Review Cell Biology

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge

Milica Nedeljkovic et al.

CELLS (2019)

添加到收藏夹

Article Oncology

Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer

Xuelei Ma et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Qiang Lan et al.

ONCOGENE (2019)

添加到收藏夹

Article Oncology

CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB

Ya-Ling Hsu et al.

BREAST CANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs

Momir Bosiljcic et al.

BREAST CANCER RESEARCH (2019)

添加到收藏夹

Article Engineering, Biomedical

An Agent-based Model for Investigating the Effect of Myeloid-Derived Suppressor Cells and its Depletion on Tumor Immune Surveillance

Armin Allahverdy et al.

JOURNAL OF MEDICAL SIGNALS & SENSORS (2019)

添加到收藏夹

Article Biology

Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies

Seyed Peyman Shariatpanahi et al.

JOURNAL OF THEORETICAL BIOLOGY (2018)

添加到收藏夹

Review Immunology

Myeloid-derived suppressor cells coming of age

Filippo Veglia et al.

NATURE IMMUNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors

Xiulan Lai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹

Review Immunology

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

Viktor Fleming et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Is adaptive therapy natural?

Frederic Thomas et al.

PLOS BIOLOGY (2018)

添加到收藏夹

Article Oncology

Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines

Sruthi Ravindranathan et al.

BREAST CANCER RESEARCH (2018)

添加到收藏夹

Article Oncology

Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer

Kenji Gonda et al.

ONCOLOGY LETTERS (2017)

添加到收藏夹

Article Oncology

Myeloid cells in circulation and tumor microenvironment of breast cancer patients

Salman M. Toor et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)

添加到收藏夹

Article Oncology

Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis

Ke Wang et al.

ONCOTARGET (2016)

添加到收藏夹

Review Oncology

Clinical significance of tumor-infiltrating lymphocytes in breast cancer

Sasha E. Stanton et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model

Ana C. Gregorio et al.

PLOS ONE (2016)

添加到收藏夹

Review Medicine, General & Internal

The fate of chemoresistance in triple negative breast cancer (TNBC)

Elma A. O'Reilly et al.

BBA CLINICAL (2015)

添加到收藏夹

Article Biochemical Research Methods

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Sebastien Benzekry et al.

PLOS COMPUTATIONAL BIOLOGY (2014)

添加到收藏夹

Review Immunology

Does the immune system naturally protect against cancer?

Alexandre Corthay

FRONTIERS IN IMMUNOLOGY (2014)

添加到收藏夹

Review Oncology

Myeloid-derived suppressor cells in breast cancer

Joseph Markowitz et al.

BREAST CANCER RESEARCH AND TREATMENT (2013)

添加到收藏夹

Review Oncology

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer

Robert Wesolowski et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

Minu K. Srivastava et al.

PLOS ONE (2012)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Robert D. Schreiber et al.

SCIENCE (2011)

添加到收藏夹

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

添加到收藏夹

Review Cell Biology

The tumor microenvironment and its contribution to tumor evolution toward metastasis

Girieca Lorusso et al.

HISTOCHEMISTRY AND CELL BIOLOGY (2008)

添加到收藏夹

Review Oncology

Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment

Diego O. Croci et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)

添加到收藏夹

Article Oncology

Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

C De Giovanni et al.

CANCER RESEARCH (2004)

添加到收藏夹

Article Multidisciplinary Sciences

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

A Diefenbach et al.

NATURE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.